This pattern is in agreement with a recent study from our group that shows a specificity of celecoxib among other selective COX-2 inhibitors in inducing lung cancer cell apoptosis and upregulating COX-2 expression [14]. This evidence concerns the gene PTGS2 and lung carcinoma.